Inspection Record

Protonify Corporation — Health Canada Inspection Findings

Health CanadaInspected 2022-09-19 16 findingsOther quality systemValidation and qualificationEquipment and facilityDeviation, CAPA, and investigationMaterial and supplier controlQuality unit oversightCleaning validationComplaint and recall handlingComputer system validation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The company's oversight of the contracted party was inadequate.

2Validation and qualification

Validation studies were not conducted in keeping with the predefined protocols.

3Equipment and facility

The job descriptions for personnel, the authority given to personnel, and/or the delegation of duties was inadequate and/or undocumented. The training of personnel in good manufacturing practices and/or the maintenance of records was inadequate.

4Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

5Other quality system

The master production documents were inadequate.

6Material and supplier control

The sampling plan for raw materials was inadequate. Each lot or batch of raw materials was not tested against the raw material specifications before it was used to fabricate a drug.

7Quality unit oversight

The annual product quality review procedure was inadequate.

8Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate. The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate. The system for reviewing, revising, and approving standard operating procedures was inadequate.

9Other quality system

The implementation of a self-inspection program was inadequate.

10Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

11Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

12Complaint and recall handling

The quality control department's handling of complaints and/or information received about drug quality was inadequate.

13Other quality system

The electronic system was not validated for its intended use.

14Computer system validation

The usage logs for the equipment used for significant processing and/or testing operations were inadequate. The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

15Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

16Other quality system

The written procedures and records for retaining samples were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-09-19. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Protonify Corporation company profile — full history Health Canada documents, 2022 Go to Findings search